KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Feb 29, 2016 $24.24 $24.24 $24.24 $24.24 38 250
Feb 26, 2016 $24.24 $24.24 $24.24 $24.24 40 275
Feb 25, 2016 $23.36 $23.36 $23.36 $23.36 41 863
Feb 24, 2016 $23.92 $23.92 $23.92 $23.92 50 325
Feb 23, 2016 $23.76 $23.76 $23.76 $23.76 47 150
Feb 22, 2016 $25.12 $25.12 $25.12 $25.12 37 550
Feb 19, 2016 $24.24 $24.24 $24.24 $24.24 77 963
Feb 18, 2016 $23.20 $23.20 $23.20 $23.20 65 113
Feb 17, 2016 $25.44 $25.44 $25.44 $25.44 54 063
Feb 16, 2016 $24.88 $24.88 $24.88 $24.88 42 013
Feb 12, 2016 $22.88 $22.88 $22.88 $22.88 57 388
Feb 11, 2016 $21.36 $21.36 $21.36 $21.36 60 275
Feb 10, 2016 $20.80 $20.80 $20.80 $20.80 66 163
Feb 09, 2016 $21.68 $21.68 $21.68 $21.68 69 313
Feb 08, 2016 $19.68 $19.68 $19.68 $19.68 113 688
Feb 05, 2016 $21.36 $21.36 $21.36 $21.36 97 388
Feb 04, 2016 $24.08 $24.08 $24.08 $24.08 77 925
Feb 03, 2016 $22.96 $22.96 $22.96 $22.96 73 500
Feb 02, 2016 $24.08 $24.08 $24.08 $24.08 71 250
Feb 01, 2016 $24.88 $24.88 $24.88 $24.88 78 675
Jan 29, 2016 $25.84 $25.84 $25.84 $25.84 64 888
Jan 28, 2016 $23.92 $23.92 $23.92 $23.92 96 450
Jan 27, 2016 $24.56 $24.56 $24.56 $24.56 76 538
Jan 26, 2016 $25.92 $25.92 $25.92 $25.92 59 625
Jan 25, 2016 $26.24 $26.24 $26.24 $26.24 75 750
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT